Literature DB >> 1576743

Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles.

E P Wei1, M A Moskowitz, P Boccalini, H A Kontos.   

Abstract

The cerebral vasodilator response induced by topical nitroglycerin and nitroprusside was examined in cats equipped with cranial windows for the observation of the cerebral microcirculation. In cats subjected to chronic unilateral trigeminal ganglionectomy, the vasodilator responses to nitroprusside and nitroglycerin were markedly depressed on the denervated side. Application of a selective calcitonin gene-related peptide (CGRP) antagonist [CGRP(8-37)] on the innervated side reduced the response to nitrodilators to the same extent as seen on the denervated side. The vasodilator response to acetylcholine was unaffected by trigeminal ganglionectomy. CGRP(8-37) almost abolished the vasodilator response to nitroglycerin and sodium nitroprusside and to CGRP, but did not affect the response to adenosine or to adenosine diphosphate. Pretreatment with LY83583, a drug that lowers cyclic GMP levels, diminished the vasodilation to CGRP and to nitroprusside but not to adenosine. We conclude that the nitrovasodilators activate sensory fibers to release CGRP, which in turn relaxes cerebral vascular smooth muscle by activating guanylate cyclase. Hence, nitrovasodilators possess a novel mechanism of action within the cephalic circulation which may explain both the occurrence of vasodilation and headache.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576743     DOI: 10.1161/01.res.70.6.1313

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  36 in total

Review 1.  The TRPA1 channel in migraine mechanism and treatment.

Authors:  S Benemei; C Fusi; Gabriela Trevisan; Pierangelo Geppetti
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

2.  Impaired vasodilator response to organic nitrates in isolated basilar arteries.

Authors:  D Martens; G Kojda
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  New targets for migraine therapy.

Authors:  Amy R Tso; Peter J Goadsby
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

4.  Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat.

Authors:  K Messlinger; A Suzuki; M Pawlak; A Zehnter; R F Schmidt
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men.

Authors:  Bart J Van der Schueren; Rebecca Blanchard; M Gail Murphy; John Palcza; Inge De Lepeleire; Anne Van Hecken; Marleen Depré; Jan N de Hoon
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

6.  Effects of adrenomedullin and calcitonin gene-related peptide on airway and pulmonary vascular smooth muscle in guinea-pigs.

Authors:  A Pinto; K Sekizawa; M Yamaya; T Ohrui; Y X Jia; H Sasaki
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  Patients with migraine with aura have increased flow mediated dilation.

Authors:  Fabrizio Vernieri; Leo Moro; Claudia Altamura; Paola Palazzo; Raffaele Antonelli Incalzi; Paolo Maria Rossini; Claudio Pedone
Journal:  BMC Neurol       Date:  2010-03-10       Impact factor: 2.474

8.  Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group.

Authors:  Ravi Gupta; Rahul Pathak; Manjeet Singh Bhatia; Basu Deb Banerjee
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

9.  Vascular pharmacology of methylene blue in vitro and in vivo: a comparison with NG-nitro-L-arginine and diphenyleneiodonium.

Authors:  Y X Wang; X Cheng; C C Pang
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Role of adenosine A2 receptors in regulation of cerebral blood flow during induced hypotension.

Authors:  Yoshikazu Kusano; German Echeverry; Greg Miekisiak; Tobias B Kulik; Shimon N Aronhime; Jiang F Chen; H Richard Winn
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-18       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.